Legal News Articles - Defective Products
July 17, 2017. By Gordon Gibb.
Atlanta, GA: A myriad of issues with regard to Ethicon Physiomesh and the accompanying Ethicon Physiomesh complaints were partially responsible for Ethicon, a subsidiary of Johnson & Johnson, triggering a market recall of their product last year.Read [ Ethicon Physiomesh Withdrawn from Market, Never Formally Recalled ]
July 16, 2017. By Gordon Gibb.
New York, NY: Raymond Warme, according to a recent Eliquis lawsuit, was prescribed the new-age blood thinner apixaban for atrial fibrillation. That was in April, 2014. Litigation brought on his behalf by his daughter and partner claim that Warme began to experience gastrointestinal bleeding within two months of starting on the drug. He would not survive.Read [ Eliquis Lawsuit Alleges Wrongful Death, Product Misrepresentation ]
July 15, 2017. By Deb Hipp.
Miami, FL: Four auto manufacturers have agreed to compensate owners of vehicles with recalled Takata airbags in a proposed class action settlement worth $553 million.Read [ Automakers Agree to Compensate Takata Airbag Recall Consumers ]
July 13, 2017. By Deb Hipp.
St. Louis, MO: A June 2017 Supreme Court ruling may hurt Missouri lawsuit claims alleging that Johnson & Johnson's talcum products caused ovarian cancer in women who used Johnson & Johnson's Baby Powder or Shower to Shower for personal hygiene.Read [ Supreme Court Ruling May Affect Talcum Powder Lawsuit Claims ]
July 13, 2017. By Jane Mundy.
Paris, FR: While Essure lawsuits are being filed in France, Canada and the US on behalf of women who have suffered complications from the permanent birth control device (and at least one death in France), gynecologists say a “small minority of women” are requesting removal. But what constitutes a small minority?Read [ Essure Sales Decline as Complaints Increase and ObGyn Tips for Removal ]
July 11, 2017. By Gordon Gibb.
Philadelphia, PA: On the day that the Philadelphia Court of Common Pleas is holding a status update and discussion on the Risperdal lawsuit file, (July 11, 2017) it’s instructive to look rearwards a year and a week to July 1, 2016 when a $70 million verdict was delivered by a Pennsylvania state court jury favoring the plaintiff in a Risperdal gynecomastia lawsuit.Read [ One Year after Blockbuster Risperdal Gynecomastia Award, Lawsuits Now Top 20,000 ]
July 10, 2017. By Jane Mundy.
:Washington, DC: Dr. Amy Reed, a physician and mother of six had surgery for uterine fibroids with a power morcelletor one year before the FDA first warned about the risk of power morcellators spreading cancer. Dr. Reed died from cancer in May—she was 44 years old.Read [ Power Morcellation Cancer Warning One Year Too Late for Doctor ]
July 8, 2017. By Gordon Gibb.
Fresno, CA: Monsanto has been trying very hard to keep the primary ingredient in Monsanto Roundup off a list of cancer-causing chemicals maintained by the state of California. Monsanto maintains that glyphosate, the key ingredient to its popular weed killer, is perfectly safe and does not cause cancer, a fact disputed by the International Agency for Research on Cancer. However, Monsanto Roundup causes cancer will indeed, migrate to a list maintained by the Office of Environmental Health Hazard Assessment after the California Supreme Court upheld a lower court ruling.Read [ Monsanto Loses Bid to Delay Placement of Roundup on Unflattering List ]
July 8, 2017. By Gordon Gibb.
New Orleans, LA: The second bellwether Xarelto lawsuit in multidistrict litigation over allegations of Xarelto bleedout in association with the new age blood thinner has gone, like the first, to the defendant. While this may prove disappointing to litigants alleging the anticoagulant is unsafe, there are still two more bellwether trials to roll out later this year, with some 15,000 cases in the federal multidistrict litigation pipeline housed in New Orleans. Additional cases are percolating at the state level in Philadelphia.Read [ Second Bellwether Xarelto Lawsuit Goes to Defendant, All Eyes on Third ]
July 7, 2017. By Deb Hipp.
St. Louis, MO: A new study suggests that some popular heartburn drugs known as proton pump inhibitors are associated with a higher risk of death.Read [ New Study Suggests Popular Heartburn Drugs Associated With a Higher Risk of Death ]
- Taxotere Hair Loss: Are Doctors Forthright with their Patients as to Risk? By Gordon Gibb (Jul-6-17)
- Concern over Rates of Depression amongst Propecia Sexual Dysfunction Patients By Gordon Gibb (Jul-6-17)
- Smith & Nephew Birmingham Hip Resurfacing Lawsuit Filed By Lucy Campbell (Jul-5-17)
- Eli Lilly & Co. Testosterone Bellwether Trials Scheduled for 2018 By Gordon Gibb (Jul-4-17)
- With Takata Falling, Airbag Injuries and Recycled Airbags Take Center Stage By Gordon Gibb (Jul-4-17)
- Federal Judge Allows Hip Implant Lawsuit to Move Forward By Deb Hipp (Jul-3-17)
- Prolift Transvaginal Mesh Introduced Without FDA Pre-Market Clearance: Report By Gordon Gibb (Jul-1-17)
- Pregnant with Mirena IUD By Jane Mundy (Jul-1-17)
- Legal Wrangling Over Cost of Asbestos Settlement Continues Long After Victim Dies By Gordon Gibb (Jul-1-17)
- Party Animal “Cocolicious” Dog Food Subject of Class Action By Brenda Craig (Jul-1-17)
- Canadians Miffed at Failed Physiomesh Approved Under FDA 510(k) Clearance By Gordon Gibb (Jun-29-17)
- Hip Replacement Patient says Better Off Without By Jane Mundy (Jun-28-17)
- Woman Burned When Pressure Cooker Explodes By Deb Hipp (Jun-27-17)
- New Jersey Man Claims Diabetes Medicine Caused His Heart Disease By Deb Hipp (Jun-27-17)
- Zimmer Biomet Shoulder Failure: Consider Rehabilitation over Revision Surgery By Jane Mundy (Jun-27-17)
- Risperdal Lawsuit Hit 18,000 and Climbing, Status Update Due in July By Gordon Gibb (Jun-25-17)
- FDA Black Box Warning Adds Fuel to Invokana Lawsuits By Brenda Craig (Jun-24-17)
- Airbag Injury to Young Teen Caused by Reused defective Airbag By Gordon Gibb (Jun-23-17)
- FDA Dresses Down St. Jude Medical over Faulty Lithium Defibrillator Batteries By Gordon Gibb (Jun-22-17)
- Are Recalled Duodenoscopes Any Safer? By Gordon Gibb (Jun-21-17)
- Recalled Catheters All Approved Through FDA 510(k) Clearance Protocol By Gordon Gibb (Jun-20-17)
- Talcum Powder Cancer Trial Not Boding Well for Johnson & Johnson By Jane Mundy (Jun-20-17)
- Trio of Eliquis Blood Thinner Lawsuits Allege Defective Product By Gordon Gibb (Jun-19-17)
- Permanent Taxotere Hair Loss for Cancer Patients a Particularly Cruel Fate By Gordon Gibb (Jun-19-17)
- Olympus Settles Four Power Morcellator Lawsuits By Deb Hipp (Jun-18-17)
- Abdominal Mesh Complaints Rise in Canada, MDL Established in the US By Jane Mundy (Jun-17-17)
- One Defendant Dismissed from Benicar Lawsuit, Daiichi Sankyo Remains By Gordon Gibb (Jun-16-17)
- Essure Banned in Another Country, Essure Victim in US wants it Banned Worldwide By Jane Mundy (Jun-15-17)
- Woman Awarded $2.1M in Fourth Pelvic Mesh Trial By Lucy Campbell (Jun-15-17)
- Seeking Help Difficult for Bipolar Man with Risperdal “Man Boobs” By Jane Mundy (Jun-14-17)
- Johnson & Johnson Asks For New Trial in $151 Million Hip Lawsuit Judgment By Deb Hipp (Jun-14-17)
- Invokana Adverse Events Subject to Much Scrutiny By Gordon Gibb (Jun-13-17)
- Hawaii Sues Three Automakers Over Defective Takata Airbags By Deb Hipp (Jun-13-17)
- Forecasting the Xarelto Bellwether Trials By Gordon Gibb (Jun-12-17)
- Proton Pump Inhibitor Lawsuit Plaintiffs Try Again For Multidistrict Litigation By Deb Hipp (Jun-10-17)
- Baldness Treatment Drugs May Raise Risk of Depression But Not Risk of Suicide in Older Men By Deb Hipp (Jun-8-17)
- Plaintiffs in Monsanto Roundup Litigation Seek Studies on Mice By Gordon Gibb (Jun-7-17)
- Botched Circumcision Case in Discovery By Brenda Craig (Jun-7-17)
- State-Based Stryker Hip Implant Failure Lawsuits Consolidated in New Jersey By Gordon Gibb (Jun-6-17)
- Merger Deal between Device Manufacturers Reveals Device Shortcomings By Gordon Gibb (Jun-6-17)